Tharimmune, Inc. financial data

Symbol
THAR on Nasdaq
Location
1200 Route 22 East, Bridgewater, NJ
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 142 % -69.9%
Debt-to-equity 239 % +790%
Return On Equity -1.24K % -760%
Return On Assets -365 % -221%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4.64M shares +304%
Common Stock, Shares, Outstanding 4.22M shares +285%
Entity Public Float 1.7M USD -56.4%
Common Stock, Value, Issued 422 USD +280%
Weighted Average Number of Shares Outstanding, Basic 2.88M shares +199%
Weighted Average Number of Shares Outstanding, Diluted 2.88M shares +199%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 5.51M USD +57.1%
General and Administrative Expense 6.6M USD +18.1%
Operating Income (Loss) -12.1M USD -33.1%
Nonoperating Income (Expense) 97.6K USD -56%
Net Income (Loss) Attributable to Parent -12M USD -35.4%
Earnings Per Share, Basic -6 USD/shares +88.8%
Earnings Per Share, Diluted -6 USD/shares +88.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.24M USD -71.6%
Assets, Current 2.53M USD -69.4%
Assets 2.53M USD -69.4%
Accounts Payable, Current 771K USD -1.71%
Accrued Liabilities, Current 1.06M USD +82.6%
Liabilities, Current 2.16M USD +38.3%
Liabilities 2.16M USD +38.3%
Retained Earnings (Accumulated Deficit) -41.3M USD -41%
Stockholders' Equity Attributable to Parent 367K USD -94.5%
Liabilities and Equity 2.53M USD -69.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.69M USD +4.82%
Net Cash Provided by (Used in) Financing Activities 206K USD -35.2%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 4.22M shares +285%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.48M USD +0.98%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.24M USD -71.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 8.47K USD +80.2%
Deferred Tax Assets, Valuation Allowance 10.2M USD +52.6%
Deferred Tax Assets, Gross 10.2M USD +52.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 41.7M USD +15.8%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 1.19M USD +87.2%
Interest Expense 15.1K USD -23.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%